DuPont (DD) is sliding as attention returns to two near-term corporate actions: the pending sale of its aramids business (including Kevlar and Nomex) and the company’s plan to seek shareholder approval for a reverse stock split. The setup creates a headline-heavy window where event risk and positioning can pressure shares even without new quarterly results.

DuPont recently disclosed it expects to complete the previously announced sale of its aramids business to Arclin on April 1, 2026. As the expected close approaches, traders are reassessing proceeds, potential transaction adjustments, and what the portfolio looks like post-close—especially given DuPont’s broader reshaping following prior separation activity. The company’s filings describe the consideration mix as cash proceeds plus a seller note and an equity interest tied to the buyer’s holding structure, which can introduce valuation sensitivity into closing-period modeling.

DuPont also said it plans to seek stockholder approval to amend its certificate of incorporation to allow a reverse stock split at the board’s discretion within a 1-for-2 to 1-for-4 range. Separately, the company’s preliminary proxy materials identify March 30, 2026 as the record date for determining which shareholders are entitled to vote, putting the topic back in focus today as that eligibility cutoff arrives.

Key next steps include any confirmation that all closing conditions for the Aramids transaction have been satisfied ahead of April 1, 2026, and any additional detail on capital return intentions after proceeds are received. On the governance side, investors will watch for a definitive meeting date and vote outcome on the reverse split authorization, along with any later decision by the board on whether to implement it and at what final ratio.